10 research outputs found
Euromanagers kunnen omgaan met de Europese diversiteit
Onlangs stelde een topmanager van een grote Nederlandse multinational de vraag: 'Kunt u uitleggen waarom tegenwoordig zoveel commotie wordt gemaakt over strategische allianties, joint ventures en andere vormen van partnership? Wat is daar zo nieuw aan? Wij vormen al tientallen jaren lang verschillende soorten partnerships met diverse partners in allerlei landen.' Met andere woorden: waar komt de plotselinge populariteit van strategic partnering vandaan? Gaat het om een tijdelijke modegril of hebben we hier te maken met een blijvend, structureel fenomeen? Dit artikel geeft een eerste antwoord op deze actuele vraag. Daamaast wordt ingegaan op de vraag welke management skills voor een effectieve strategic partnering noodzakelijk zijn. De huidige ontwikkelingen in de omgeving van internationaal opererende bedrijven vragen om ondernemingsleiders die veel ervaring hebben in uiteenlopende nationale culturen en die sterk zijn in het leggen en onderhouden van externe contacten. Opvallend is de mening van The Wall Street Journal Europe dat de nieuwe stijl Eurotopmanagers een voorsprong hebben op hun collega's uit de VS. Maar is dat waar? Beschikken Europese managers inderdaad over meer partnering skills dan hun collega's uit de VS en Japan
Brain development in adolescents at ultra-high risk for psychosis : Longitudinal changes related to resilience
BACKGROUND: The main focus of studies of individuals at ultra-high risk for psychosis (UHR) has been on identifying brain changes in those individuals who will develop psychosis. However, longitudinal studies have shown that up to half of UHR individuals are resilient, with symptomatic remission and good functioning at follow-up. Yet little is known about brain development in resilient individuals. Therefore, the aim of this study was to investigate differences in brain development between resilient and non-resilient individuals. METHODS: A six-year longitudinal structural MRI study was performed with up to three scans per individual. The final sample consisted of 48 UHR individuals and 48 typically developing controls with a total of 225 MRI-scans, aged 12-20 years at the time of the first MRI-scan and matched for age, gender and number of follow-up scans. At six-year follow-up, 35 UHR individuals were divided in resilient (good functional outcome) and non-resilient (poor functional outcome) subgroups, defined by the modified Global Assessment of Functioning. The main outcome measures were developmental changes in MR-based measures of cortical and subcortical anatomy. RESULTS: We found widespread differences in volume of frontal, temporal and parietal cortex between resilient and non-resilient individuals. These were already present at baseline and remained stable over development (12-24 years). Furthermore, there were differences in the development of cortical surface area in frontal regions including cingulate gyrus. CONCLUSIONS: Developmental differences may reflect compensatory neural mechanisms, where better functioning in resilient individuals leads to less tissue loss over development
Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience
Background: The main focus of studies of individuals at ultra-high risk for psychosis (UHR) has been on identifying brain changes in those individuals who will develop psychosis. However, longitudinal studies have shown that up to half of UHR individuals are resilient, with symptomatic remission and good functioning at follow-up. Yet little is known about brain development in resilient individuals. Therefore, the aim of this study was to investigate differences in brain development between resilient and non-resilient individuals.
Methods: A six-year longitudinal structural MRI study was performed with up to three scans per individual. The final sample consisted of 48 UHR individuals and 48 typically developing controls with a total of 225 MRI-scans, aged 12â20Â years at the time of the first MRI-scan and matched for age, gender and number of follow-up scans. At six-year follow-up, 35 UHR individuals were divided in resilient (good functional outcome) and non-resilient (poor functional outcome) subgroups, defined by the modified Global Assessment of Functioning. The main outcome measures were developmental changes in MR-based measures of cortical and subcortical anatomy.
Results: We found widespread differences in volume of frontal, temporal and parietal cortex between resilient and non-resilient individuals. These were already present at baseline and remained stable over development (12â24Â years). Furthermore, there were differences in the development of cortical surface area in frontal regions including cingulate gyrus.
Conclusions: Developmental differences may reflect compensatory neural mechanisms, where better functioning in resilient individuals leads to less tissue loss over development
Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study
Background: During the COVID-19 pandemic, the scarcity of resources has necessitated triage of critical care for patients with the disease. In patients aged 65 years and older, triage decisions are regularly based on degree of frailty measured by the Clinical Frailty Scale (CFS). However, the CFS could also be useful in patients younger than 65 years. We aimed to examine the association between CFS score and hospital mortality and between CFS score and admission to intensive care in adult patients of all ages with COVID-19 across Europe. Methods: This analysis was part of the COVID Medication (COMET) study, an international, multicentre, retrospective observational cohort study in 63 hospitals in 11 countries in Europe. Eligible patients were aged 18 years and older, had been admitted to hospital, and either tested positive by PCR for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or were judged to have a high clinical likelihood of having SARS-CoV-2 infection by the local COVID-19 expert team. CFS was used to assess level of frailty: fit (CFS1â3), mildly frail (CFS4â5), or frail (CFS6â9). The primary outcome was hospital mortality. The secondary outcome was admission to intensive care. Data were analysed using a multivariable binary logistic regression model adjusted for covariates (age, sex, number of drugs prescribed, and type of drug class as a proxy for comorbidities). Findings: Between March 30 and July 15, 2020, 2434 patients (median age 68 years [IQR 55â77]; 1480 [61%] men, 954 [30%] women) had CFS scores available and were included in the analyses. In the total sample and in patients aged 65 years and older, frail patients and mildly frail patients had a significantly higher risk of hospital mortality than fit patients (total sample: CFS6â9 vs CFS1â3 odds ratio [OR] 2·71 [95% CI 2·04â3·60], p<0·0001 and CFS4â5 vs CFS1â3 OR 1·54 [1·16â2·06], p=0·0030; age â„65 years: CFS6â9 vs CFS1â3 OR 2·90 [2·12â3·97], p<0·0001 and CFS4â5 vs CFS1â3 OR 1·64 [1·20â2·25], p=0·0020). In patients younger than 65 years, an increased hospital mortality risk was only observed in frail patients (CFS6â9 vs CFS1â3 OR 2·22 [1·08â4·57], p=0·030; CFS4â5 vs CFS1â3 OR 1·08 [0·48â2·39], p=0·86). Frail patients had a higher incidence of admission to intensive care than fit patients (CFS6â9 vs CFS1â3 OR 1·54 [1·21â1·97], p=0·0010), whereas mildly frail patients had a lower incidence than fit patients (CFS4â5 vs CFS1â3 OR 0·71 [0·55â0·92], p=0·0090). Among patients younger than 65 years, frail patients had an increased incidence of admission to intensive care (CFS6â9 vs CFS1â3 OR 2·96 [1·98â4·43], p<0·0001), whereas mildly frail patients had no significant difference in incidence compared with fit patients (CFS4â5 vs CFS1â3 OR 0·93 [0·63â1·38], p=0·72). Among patients aged 65 years and older, frail patients had no significant difference in the incidence of admission to intensive care compared with fit patients (CFS6â9 vs CFS1â3 OR 1·27 [0·92â1·75], p=0·14), whereas mildly frail patients had a lower incidence than fit patients (CFS4â5 vs CFS1â3 OR 0·66 [0·47â0·93], p=0·018). Interpretation: The results of this study suggest that CFS score is a suitable risk marker for hospital mortality in adult patients with COVID-19. However, treatment decisions based on the CFS in patients younger than 65 years should be made with caution. Funding: LOEY Foundation
Lâimpresa significante
Since 2008, a research team of Management Department (Caâ Foscari University of Venice) has been conducting various action-research projects to support the strategy reconsideration of many businesses, with the supervision of the author of the present paper. These experiences lead to the Significant Business Manifesto, which aspires to imagine a new entrepreneurial model for all the Italian businesses, but inspiring even for the single one. The proposed model is structured on gradually more actionable levels: vision, mission, strategy, and business model. Such levels should characterize the ideal type of Italian business and should guide the related questions which every actual business needs to answer